- The Health Impact Fund: Boosting Pharmaceutical Innovation Without Obstructing Free Access.Thomas Pogge - 2009 - Cambridge Quarterly of Healthcare Ethics 18 (1):78.details
|
|
Human rights and global health: A research program.Thomas W. Pogge - 2005 - Metaphilosophy 36 (1‐2):182-209.details
|
|
In favour of a Millian proposal to reform biomedical research.Julian Reiss - 2010 - Synthese 177 (3):427 - 447.details
|
|
Biomedical research, neglected diseases, and well-ordered science.Julian Reiss & Philip Kitcher - 2009 - Theoria: Revista de Teoría, Historia y Fundamentos de la Ciencia 24 (3):263-282.details
|
|
Biomedical Research, Neglected Diseases, and Well-Ordered Science.Julian Reiss & Philip Kitcher - 2010 - Theoria 24 (3):263-282.details
|
|
Biomedical Research, Neglected Diseases, and Well-Ordered Science.Philip Kitcher - 2009 - Theoria: Revista de Teoría, Historia y Fundamentos de la Ciencia 24 (3):263-282.details
|
|
The health impact fund: A useful supplement to the patent system?Aidan Hollis - 2008 - Public Health Ethics 1 (2):124-133.details
|
|
Explanatory pluralism in the medical sciences: Theory and practice.Leen De Vreese, Erik Weber & Jeroen Van Bouwel - 2010 - Theoretical Medicine and Bioethics 31 (5):371-390.details
|
|
Politics, method, and medical research.James Robert Brown - 2008 - Philosophy of Science 75 (5):756-766.details
|
|
Lessons from the vioxx debacle: What the privatization of science can teach us about social epistemology.Justin Biddle - 2007 - Social Epistemology 21 (1):21 – 39.details
|
|
The Community of Science®.James R. Brown - 2008 - In Martin Carrier, Don Howard & Janet A. Kourany (eds.), The Challenge of the Social and the Pressure of Practice: Science and Values Revisited. University of Pittsburgh Press.details
|
|
Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.Michael Kremer & Rachel Glennerster - 2005 - Ethics and International Affairs 19 (3).details
|
|